Cell and Gene Therapy Cold Chain Management: from Logistics to Product Design
Thursday, September 5, 2024 04:45 PM - 05:45 PM
F2
Concurrent Session
Chair:
- Dominic Clarke, PhD, Cryoport Systems, United States
Speakers:
- Lindsay Davies, PhD, FHEA, NextCell Pharma, Sweden - Development of an “off the shelf” Cryopreserved MSC Therapy
- Ivo Urh, MSc, Fujifilm Irvine Scientific, United Kingdom - Making the Right Decision the First Time: Closing the distance between research scale and commercialization
- Dominic Clarke, PhD, Cryoport Systems, United States - Enabling the Outcome Through Integrated Supply Chain Solutions
This session will cover the impact of cold chain storage, distribution and stability on your product development and logistics processes. Speakers will cover topics such as modes of transport and shipping through to key cold chain management considerations in the design and development of your product.
Session Objectives
- An understanding of important cold chain considerations in the development of your cell and gene therapy product
- An appreciation of the logistics involved in the distribution and storage of a temperature regulated drug product
- Evaluation of new innovations in addressing bottlenecks in cold chain management of cell and gene therapy products
